Concepedia

Monthly docetaxel and weekly gemcitabine in metastatic breast cancer: A phase II trial

Leslie R. Laufman, C. Harris Spiridonidis, Jessica Pritchard, Ralph W. Roach, Jeffrey Zangmeister, N.R. Larrimer, Timothy M. Moore, Michal Segal, J. B. Jones, Tejal Patel,

Annals of Oncology · 2001 · 53 citations · 28 references

DOIFull text

Open access

Concepts

References

28

Nonparametric Estimation from Incomplete Observations

Edward L. Kaplan, Paul Meier · Journal of the American Statistical Association · 1958 · 39.1K citations

, , +10

One-Sample Multiple Testing Procedure for Phase II Clinical Trials

Thomas R. Fleming · Biometrics · 1982 · 997 citations

, , +13

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.

James L. Abbruzzese, Ralf Grunewald, Elizabeth A. Weeks et al. · Journal of Clinical Oncology · 1991 · 759 citations

, , +13

Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast Cancer

Stephen Chan, Kay Friedrichs, D. Noel et al. · Journal of Clinical Oncology · 1999 · 638 citations

, , +16

Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing Chemotherapy

Jean‐Marc Nabholtz, H.-J. Senn, W.R. Bezwoda et al. · Journal of Clinical Oncology · 1999 · 506 citations

, , +12